You make a great point. Right now it seems to me that AGN is talking about RT002 in the investment community and it has been somewhat effective there.
Isn't RT002 is being talked about in the medical community in "what if" terms. What can RVNC legally do/say before approval to possible patients/doctors? For that matter do you know what AGN can legally say and do?
Not necessarily as any pre launch campaign is ok as long they clearest disclose they are waiting on approval.
The key aspect to such an heads start is they see it as a big cosmetic campaign which requires building growing excitement into launch date among users both current & potential who may be lured due to long acting effect of RT002.
Certainly getting early buy-in from providers could be part of agenda so that co is well prepared when it comes to pricing (hopefully with premium).
Market Data 
Markets 
AI
